Vitamin D deficiency in the pathogenesis of leiomyoma and intravascular leiomyomatosis: A case report and review of the literature.
ER, oestrogen receptor
PgR, progesterone receptor
SMA, smooth muscle actin
Journal
Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
05
08
2020
revised:
01
12
2020
accepted:
06
12
2020
entrez:
28
12
2020
pubmed:
29
12
2020
medline:
29
12
2020
Statut:
epublish
Résumé
This is a case of recurrent intravascular leiomyomatosis in a pre-menopausal woman of African-Caribbean heritage. She presented in 2006 with multiple uterine leiomyomata, tumour invading the inferior vena cava (IVC) extending into the right atrium, and pulmonary metastases. Her initial presentation was treated surgically. On recurrence she was treated by oestrogen suppression using a combination of goserelin and letrozole, with a substantial response. She subsequently reported further regression of disease following exposure to strong sunlight enabling her to discontinue oestrogen suppression without relapse. The hypothesis is that the benefit was due to vitamin D. The role of hypovitaminosis D in the pathogenesis of uterine leiomyomata is discussed, including epidemiology data demonstrating a link between ethnicity and risk and the proven mechanisms by which vitamin D controls oestrogen and progesterone receptor expression and influences other signalling pathways involved in the pathogenesis of leiomyomas. Data indicating the intermediate malignancy nature of intravascular leiomyomatosis, are discussed. We are not aware of other reports indicating a link between intravascular leiomyomatosis and a lack of vitamin D.
Identifiants
pubmed: 33364287
doi: 10.1016/j.gore.2020.100681
pii: S2352-5789(20)30147-8
pmc: PMC7750323
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100681Informations de copyright
© 2020 The Authors. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Clin Endocrinol Metab. 2011 Apr;96(4):E754-62
pubmed: 21289245
Medicine (Baltimore). 2016 Dec;95(52):e5698
pubmed: 28033263
J Obstet Gynaecol Res. 2010 Apr;36(2):454-8
pubmed: 20492407
Epidemiology. 2013 May;24(3):447-53
pubmed: 23493030
J Clin Endocrinol Metab. 2016 Apr;101(4):1542-51
pubmed: 26820714
Mod Pathol. 2016 May;29(5):500-10
pubmed: 26892441
J Clin Endocrinol Metab. 2013 Aug;98(8):E1374-8
pubmed: 23824422
Pathol Int. 1998 Nov;48(11):892-6
pubmed: 9832059
Am J Clin Nutr. 2002 Jul;76(1):187-92
pubmed: 12081833
J Clin Endocrinol Metab. 2015 Apr;100(4):E572-82
pubmed: 25625804
Am J Obstet Gynecol. 2014 Mar;210(3):194-9
pubmed: 23942040
Fertil Steril. 2011 Jan;95(1):247-53
pubmed: 20736132